Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.
Altavilla A, Casadei C, Lolli C, Menna C, Ravaglia G, Gurioli G, Farolfi A, Brighi N, Conteduca V, Burgio SL, Schepisi G, Rossi L, Gargiulo S, Lisotti I, De Giorgi U.
Altavilla A, et al. Among authors: menna c.
Expert Opin Pharmacother. 2020 Dec;21(17):2091-2099. doi: 10.1080/14656566.2020.1803281. Epub 2020 Aug 12.
Expert Opin Pharmacother. 2020.
PMID: 32783772
Review.